Join us online for our next Food Supplements Special Interest Group (SIG) to hear about how, within the space of a couple of years, CBD ingestibles have transitioned from a lightly regulated consumer product to potentially being classified as a narcotic and banned from the shelves of retail outlets in Europe. How did this happen and what’s the impact on the CBD industry?

We invite you to hear some of the facts around CBD, providing clarity about its current status and the future challenges and opportunities for companies operating in this sector. All of this will be presented by our speakers, Janet Worrell, Head of Regulatory at JensonR+ and Greer Deal, Director of Global Regulatory Services

As well as the opportunity to hear some facts about CBD you can take part in a question and answer session.

DURATION: 1 Hour

TO BOOK YOUR PLACE PLEASE CLICK HERE

This free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses, the value of which is £127, but is delivered completely free of charge to participants.

Speaker Profiles:

Janet Worrell, Head of Regulatory, JensonR+

Janet is an experienced regulatory affairs professional, having supported a diverse portfolio of products, for a number of companies across the East Midlands. Janet’s experience covers early concept development, food supplements, over the counter (OTC) medicines, inhaled therapies and clinical trial applications. Janet enjoys collaborating with companies to develop their regulatory strategy to deliver commercial success. Janet is an independent board member of the East Midlands Academic Health Science Network supporting innovation within NHS.

Greer Deal, Director, Global Regulatory Services

Greer has over 25 years’ experience in the life science sector and 13 years ago she co-founded Global Regulatory Services with her husband, Bobby Deal. One of their first projects involved medicinal cannabis and since then the company has become increasingly involved in plant-derived products whether medicinal, food or cosmetics. Since January 2019, Global Regulatory Services has become known as the leading advisers to companies in the cannabis industry with particular expertise in navigating the EU Novel Foods Regulation.